Literature DB >> 14689466

Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes.

Anima Ghosal1, Neil Hapangama, Yuan Yuan, Xiaowen Lu, Debra Horne, James E Patrick, Shmuel Zbaida.   

Abstract

Cytochrome P450 (CYP) substrates that yield fluorescent metabolites were used for rapid screening of drug metabolism activities of 13 recombinant human cytochromes P450, human liver microsomes and human hepatocytes. Reproducible results were obtained using a fluorescent plate reader (CytoFluor) more expediently than those generated using conventional HPLC methods. Typically, results for 96 samples were obtained with the plate reader in less than 10 min as opposed to 15-35 min/sample required by conventional HPLC. The fluorescent substrates used to measure CYP activities were as follows: 3-cyano-7-ethoxycoumarin (CEC) for CYP1A1, CYP1A2, CYP2C9 and CYP2C19; 7-ethoxyresorufin (7-ER) for CYP1A1, CYP1A2 and CYP1B1; 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) for CYP2D6; dibenzylfluorescein (DBF) for CYP3A4, CYP3A5 and CYP2C8; 7-methoxy-4-trifluoromethylcoumarin (7-MFC) for CYP2E1, CYP2B6 and CYP2C18; and coumarin for CYP2A6. The chemical inhibition and correlation data indicated that the following substrates can be used as specific functional probes for individual cytochrome P450 present in human liver microsomes: coumarin for CYP2A6 (r=0.82), AMMC for CYP2D6 (r=0.83) and DBF for CYP3A4 (r=0.92). The fluorescent plate reader was found to be useful for the rapid assessment of CYP activities (positive control) in both intact cells and subcellular fractions. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14689466     DOI: 10.1002/bdd.374

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  15 in total

1.  Role of intracellular calcium and phospholipase A2 in arachidonic acid-induced toxicity in liver cells overexpressing CYP2E1.

Authors:  Andres A Caro; Arthur I Cederbaum
Journal:  Arch Biochem Biophys       Date:  2006-11-03       Impact factor: 4.013

2.  A highly sensitive fluorogenic probe for cytochrome P450 activity in live cells.

Authors:  Melissa M Yatzeck; Luke D Lavis; Tzu-Yuan Chao; Sunil S Chandran; Ronald T Raines
Journal:  Bioorg Med Chem Lett       Date:  2008-06-10       Impact factor: 2.823

3.  Multigene predictors of tacrolimus exposure in kidney transplant recipients.

Authors:  Rebecca A Pulk; David S Schladt; William S Oetting; Weihua Guan; Ajay K Israni; Arthur J Matas; Rory P Remmel; Pamala A Jacobson
Journal:  Pharmacogenomics       Date:  2015-06-12       Impact factor: 2.533

4.  Functional and structural characterisation of common cytochrome P450 2D6 allelic variants-roles of Pro34 and Thr107 in catalysis and inhibition.

Authors:  Amelia Nathania Dong; Nafees Ahemad; Yan Pan; Uma Devi Palanisamy; Beow Chin Yiap; Chin Eng Ong
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-04-26       Impact factor: 3.000

5.  Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro.

Authors:  Yan Pan; Kai Hung Tiong; Badrul Amini Abd-Rashid; Zakiah Ismail; Rusli Ismail; Joon Wah Mak; Chin Eng Ong
Journal:  J Nat Med       Date:  2013-07-24       Impact factor: 2.343

6.  Geldanamycin, an inhibitor of Hsp90 increases cytochrome P450 2E1 mediated toxicity in HepG2 cells through sustained activation of the p38MAPK pathway.

Authors:  Aparajita Dey; Arthur I Cederbaum
Journal:  Arch Biochem Biophys       Date:  2007-03-08       Impact factor: 4.013

7.  Altered human CYP3A4 activity caused by Antley-Bixler syndrome-related variants of NADPH-cytochrome P450 oxidoreductase measured in a robust in vitro system.

Authors:  Daniela Moutinho; Christopher C Marohnic; Satya P Panda; José Rueff; Bettie Sue Masters; Michel Kranendonk
Journal:  Drug Metab Dispos       Date:  2012-01-17       Impact factor: 3.922

8.  Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara.

Authors:  Denise C Endringer; Keller G Guimarães; Tamara P Kondratyuk; John M Pezzuto; Fernão C Braga
Journal:  J Nat Prod       Date:  2008-05-08       Impact factor: 4.050

9.  Selective Targeting of Heme Protein in Cytochrome P450 and Nitric Oxide Synthase by Diphenyleneiodonium.

Authors:  John T Szilagyi; Vladimir Mishin; Diane E Heck; Yi-Hua Jan; Lauren M Aleksunes; Jason R Richardson; Ned D Heindel; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2016-02-14       Impact factor: 4.849

10.  Toward a systems approach to cytochrome P450 ensemble: interactions of CYP2E1 with other P450 species and their impact on CYP1A2.

Authors:  Nadezhda Y Davydova; Bikash Dangi; Marc A Maldonado; Nikita E Vavilov; Victor G Zgoda; Dmitri R Davydov
Journal:  Biochem J       Date:  2019-12-12       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.